AIMS: The objective of this study was to examine the association between the different patterns of left ventricular (LV) remodelling/hypertrophy on all-cause and cardiovascular mortality in patients with aortic stenosis (AS). METHODS AND RESULTS: In total, 747 consecutive patients (69 ± 14 years, 57% men) with AS and preserved LV ejection fraction were included in this study. According to LV mass index and relative wall thickness, patients were classified into four LV patterns: normal, concentric remodelling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH). One hundred and sixteen patients (15%) had normal pattern, 66 (9%) had EH, 169 (23%) had CR, and 396 (53%) had CH. During a median follow-up of 6.4 years, 339 patients died (242 from cardiovascular causes). CH was associated with higher risk of all-cause mortality compared with the three other LV patterns (all P < 0.05). After multivariable adjustment, CH remained associated with higher risk of mortality (HR = 1.27, 95% CI 1.01-1.61, P = 0.046). There was a significant interaction (P < 0.05) between sex and CH with regards to the impact on mortality: CH was associated with worse outcome in women (P = 0.0001) but not in men (P = 0.22). In multivariable analysis, CH remained associated with higher risk of worse outcome in women (HR = 1.56, 95% CI 1.08-2.24, P = 0.018). CONCLUSIONS: This study shows that CH was independently associated with increased risk of mortality in AS patients with preserved ejection fraction. This association was observed in women but not in men. The pattern of LV remodelling/hypertrophy should be integrated in the risk stratification process in patients with AS. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The objective of this study was to examine the association between the different patterns of left ventricular (LV) remodelling/hypertrophy on all-cause and cardiovascular mortality in patients with aortic stenosis (AS). METHODS AND RESULTS: In total, 747 consecutive patients (69 ± 14 years, 57% men) with AS and preserved LV ejection fraction were included in this study. According to LV mass index and relative wall thickness, patients were classified into four LV patterns: normal, concentric remodelling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH). One hundred and sixteen patients (15%) had normal pattern, 66 (9%) had EH, 169 (23%) had CR, and 396 (53%) had CH. During a median follow-up of 6.4 years, 339 patients died (242 from cardiovascular causes). CH was associated with higher risk of all-cause mortality compared with the three other LV patterns (all P < 0.05). After multivariable adjustment, CH remained associated with higher risk of mortality (HR = 1.27, 95% CI 1.01-1.61, P = 0.046). There was a significant interaction (P < 0.05) between sex and CH with regards to the impact on mortality: CH was associated with worse outcome in women (P = 0.0001) but not in men (P = 0.22). In multivariable analysis, CH remained associated with higher risk of worse outcome in women (HR = 1.56, 95% CI 1.08-2.24, P = 0.018). CONCLUSIONS: This study shows that CH was independently associated with increased risk of mortality in AS patients with preserved ejection fraction. This association was observed in women but not in men. The pattern of LV remodelling/hypertrophy should be integrated in the risk stratification process in patients with AS. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Barbara P Lund; Christa Gohlke-Bärwolf; Dana Cramariuc; Anne B Rossebø; Ashild E Rieck; Eva Gerdts Journal: Am J Cardiol Date: 2010-03-30 Impact factor: 2.778
Authors: G de Simone; R B Devereux; S R Daniels; G Mureddu; M J Roman; T R Kimball; R Greco; S Witt; F Contaldo Journal: Circulation Date: 1997-04-01 Impact factor: 29.690
Authors: Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Luis Moura; Bogdan A Popescu; Eustachio Agricola; Jean-Luc Monin; Luc A Pierard; Luigi Badano; Jose L Zamorano Journal: Eur J Echocardiogr Date: 2010-04
Authors: Marie-Annick Clavel; Maxime Berthelot-Richer; Florent Le Ven; Romain Capoulade; Abdellaziz Dahou; Jean G Dumesnil; Patrick Mathieu; Philippe Pibarot Journal: J Am Coll Cardiol Date: 2015-02-24 Impact factor: 24.094
Authors: Romain Capoulade; Eric Larose; Patrick Mathieu; Marie-Annick Clavel; Abdellaziz Dahou; Marie Arsenault; Elisabeth Bédard; Samuel Larue-Grondin; Florent Le Ven; Jean G Dumesnil; Jean-Pierre Després; Philippe Pibarot Journal: Can J Cardiol Date: 2014-02-19 Impact factor: 5.223
Authors: Marc R Dweck; Sanjiv Joshi; Timothy Murigu; Francisco Alpendurada; Andrew Jabbour; Giovanni Melina; Winston Banya; Ankur Gulati; Isabelle Roussin; Sadaf Raza; Nishant A Prasad; Rick Wage; Cesare Quarto; Emiliano Angeloni; Simone Refice; Mary Sheppard; Stuart A Cook; Philip J Kilner; Dudley J Pennell; David E Newby; Raad H Mohiaddin; John Pepper; Sanjay K Prasad Journal: J Am Coll Cardiol Date: 2011-09-13 Impact factor: 24.094
Authors: Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367
Authors: Shmuel Chen; Bjorn Redfors; Tamim Nazif; Ajay Kirtane; Aaron Crowley; Ori Ben-Yehuda; Samir Kapadia; Matthew T Finn; Sachin Goel; Brian R Lindman; Maria C Alu; Katherine H Chau; Vinod H Thourani; Torsten P Vahl; Pamela S Douglas; Susheel K Kodali; Martin B Leon Journal: Eur Heart J Date: 2020-02-21 Impact factor: 35.855
Authors: E Mara Vollema; Gurpreet K Singh; Edgard A Prihadi; Madelien V Regeer; See Hooi Ewe; Arnold C T Ng; Bart J A Mertens; Robert J M Klautz; Nina Ajmone Marsan; Jeroen J Bax; Victoria Delgado Journal: Eur Heart J Cardiovasc Imaging Date: 2019-10-01 Impact factor: 6.875
Authors: Jan Stassen; See Hooi Ewe; Kensuke Hirasawa; Steele C Butcher; Gurpreet K Singh; Mohammed R Amanullah; Kenny Y K Sin; Zee P Ding; Stephan M Pio; Nicholas W S Chew; Ching Hui Sia; William K F Kong; Kian Keong Poh; David J Cohen; Philippe Généreux; Martin B Leon; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax Journal: Eur Heart J Cardiovasc Imaging Date: 2022-09-10 Impact factor: 9.130